Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8957633 | International Journal of Women's Dermatology | 2018 | 7 Pages |
Abstract
Providers can look for signs of QoL impairment in patients with CLE by asking questions related to body image, mental health, social isolation, and coping mechanisms. Future QoL measures can include the effect of CLE-specific attributes such as scarring and dyspigmentation to empower patients' voices in determining therapeutic efficacy in future clinical trials. Findings from our study have added a new understanding of daily experiences that were elicited directly from patients with CLE.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
M.E. BPharm, PhD, C.M. PhD, D. Lin, F. Imarhia, C. Maxey, B.F. PhD,